Pharmacological classification of central post-stroke pain: comparison with the results of chronic motor cortex stimulation therapy

被引:97
作者
Yamamoto, T [1 ]
Katayama, Y [1 ]
Hirayama, T [1 ]
Tsubokawa, T [1 ]
机构
[1] NIHON UNIV, RES CTR, TOKYO, JAPAN
关键词
thalamic pain; morphine; thiamylal; ketamine; motor cortex;
D O I
10.1016/S0304-3959(97)00028-6
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
In an attempt to clarify the neurochemical background of central post-stroke pain and to undertake a pharmacological analysis, the basic pharmacological characteristics of this intractable pain syndrome were investigated by the morphine, thiamylal and ketamine tests. In addition, the correlation between the pharmacological characteristics and the effects of chronic motor cortex stimulation therapy was examined. The study employed 39 central post-stroke pain patients who had intractable hemibody pain associated with dysesthesias,and radiologically demonstrated lesions in the thalamic area (thalamic pain, n = 25) or suprathalamic area (suprathalamic pain, n = 14). The pharmacological evaluations showed that definite pain reduction occurred in eight of the 39 cases (20.5%) by the morphine test, in 22 of the 39 cases (56.4%) by the thiamylal test, and in 11 of 23 cases (47.8%) by the ketamine test. Based on these pharmacological assessments, there was no obvious difference between thalamic and suprathalamic pain. A comparison of the long-term follow-up results of chronic motor cortex stimulation therapy revealed that thiamylal and ketamine-sensitive and morphine-resistant cases displayed long-lasting pain reduction with chronic motor cortex stimulation therapy, whereas the remaining cases did not show good results. We conclude that pharmacological classification of central post-stroke pain by the morphine, thiamylal and ketamine tests could be useful for predicting the effects of chronic motor cortex stimulation therapy. It has recently been suggested that excitatory amino acids may be involved in the development of central post-stroke pain. However, the fact that only 23 of the present 39 cases (59.0%) of thalamic and suprathalamic pain were sensitive to the thiamylal or ketamine test reflects the complex pharmacological background and the difficulties associated with treating central post-stroke pain. (C) 1997 International Association for the Study of Pain. Published by Elsevier Science B.V.
引用
收藏
页码:5 / 12
页数:8
相关论文
共 71 条
[1]   STIMULATION OF INTERNAL CAPSULE FOR RELIEF OF CHRONIC PAIN [J].
ADAMS, JE ;
HOSOBUCHI, Y ;
FIELDS, HL .
JOURNAL OF NEUROSURGERY, 1974, 41 (06) :740-744
[2]  
AGNEW DC, 1982, ADV PAIN RES THER, V5, P941
[3]  
ALBEFESSARD D, 1982, ADV PAIN RES THER, V5, P691
[4]   RESPONSE OF CHRONIC NEUROPATHIC PAIN SYNDROMES TO KETAMINE - A PRELIMINARY-STUDY [J].
BACKONJA, M ;
ARNDT, G ;
GOMBAR, KA ;
CHECK, B ;
ZIMMERMANN, M .
PAIN, 1994, 56 (01) :51-57
[5]   THALAMIC INFARCTS - CLINICAL SYNDROMES, ETIOLOGY, AND PROGNOSIS [J].
BOGOUSSLAVSKY, J ;
REGLI, F ;
USKE, A .
NEUROLOGY, 1988, 38 (06) :837-848
[6]   CENTRAL POST-STROKE PAIN - A STUDY OF THE MECHANISMS THROUGH ANALYSES OF THE SENSORY ABNORMALITIES [J].
BOIVIE, J ;
LEIJON, G ;
JOHANSSON, I .
PAIN, 1989, 37 (02) :173-185
[7]   ACUTE, CHRONIC AND DIFFERENTIAL-EFFECTS OF SEVERAL ANESTHETIC BARBITURATES ON GLUTAMATE RECEPTOR ACTIVATION IN NEURONAL CULTURE [J].
CAI, ZW ;
MCCASLIN, PP .
BRAIN RESEARCH, 1993, 611 (02) :181-186
[8]  
CANAVERO S, 1995, J NEUROSURG, V83, P1117
[9]  
Cassinari V, 1969, CENTRAL PAIN NEUROSU
[10]  
CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516